31.   The panel voted to recommend approval of the new use for Taxol, currently approved for fighting breast and ovarian cancer.

32.   The panel voted unanimously to approve the device, provided the company meets several conditions.

33.   The panel will vote later today on whether the FDA should allow the two companies to distribute Myotrophin to patients before it is formally approved.

34.   The panel will vote on the plan after the public has a chance to comment on the proposal.

35.   The military judge hearing the case, Peter E. Brownback III, did not disclose how the panel voted.

36.   The panel voted to eliminate the Bureau of Mines, a part of the Interior Department that conducts research into mine safety, environmental issues, and technologies.

37.   The panel voted to keep two others tests, one for syphilis and the other for another type of hepatitis.

38.   The panel will vote later today on a recommendation to the FDA regarding the new use for Amphotec.

39.   The panel will vote on a recommendation later this afternoon.

40.   The panel will vote this afternoon whether to recommend FDA approval of the product.